1. Home
  2. Primary Antibodies

Search Result - Primary Antibodies

  • anti-CD18 / LFA1 beta antibody [C71/16] (Biotin)
  • Cat. No: ARG20847 　(Rat mAb)
  • Reactivity: Ms
  • Application: ELISA, FACS, ICC/IF, IHC-Fr, IHC-P, WB
  • Specificity: Mouse CD18. The clone C71/16 has not been reported to inhibit cell adhesion.
  • Conjugation: Biotin
  • anti-CD22 antibody [2D6]
  • Cat. No: ARG20867 　(Rat mAb)
  • Reactivity: Ms
  • Application: FACS, ICC/IF, IHC-Fr, IHC-P, IP, Cell-Act
  • Specificity: Mouse CD22.
  • Conjugation: Un-conjugated
  • anti-CD25 antibody [7D4]
  • Cat. No: ARG20879 　(Rat mAb)
  • Reactivity: Ms
  • Application: BL, FACS, IHC-Fr, IP, Neut, Depletion
  • Specificity: Mouse CD25. The clone 7D4 reacts with an epitope between amino acids 125 and 212 that is distinct from that recognized by The clone 3C7. While The clone 7D4 does not block the binding of IL-2 to CD25, when used in combination with The clone 3C7 it results in higher levels of inhibition of IL-2-driven proliferation than either of these two monoclonal antibodies alone.
  • Conjugation: Un-conjugated
  • anti-CD25 antibody [7D4] (PE-Cyanine 7)
  • Cat. No: ARG20886 　(Rat mAb)
  • Reactivity: Ms
  • Application: BL, FACS, IHC-Fr, Neut, Depletion
  • Specificity: Mouse CD25. The clone 7D4 reacts with an epitope between amino acids 125 and 212 that is distinct from that recognized by The clone 3C7. While The clone 7D4 does not block the binding of IL-2 to CD25, when used in combination with The clone 3C7 it results in higher levels of inhibition of IL-2-driven proliferation than either of these two monoclonal antibodies alone.
  • Conjugation: PE-Cyanine 7
  • anti-CD62E / E-Selectin antibody [1.2B6] (FITC)
  • Cat. No: ARG20935 　(Mouse mAb)
  • Reactivity: Hu, Pig
  • Application: BL, ELISA, FACS, ICC/IF, IHC-Fr, WB
  • Specificity: Human CD62E & CD62P/Porcine CD62E. The clone 1.2B6 recognizes a common epitope shared by CD62E and CD62P.
  • Conjugation: FITC
arigo nuts about antibodies
© 2014-2025, arigo Biolaboratories Corp., All rights reserved